Results 291 to 300 of about 19,606,378 (347)

Chronic illness and extreme performance: Type 1 diabetes in ultra-endurance. [PDF]

PLoS One
Vauthier JC, Choley L, Kabuth B.
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes. [PDF]

Front Endocrinol (Lausanne)
Zhou KJ, Rong SJ, Liu YC, Sun F, Wang T, Yu QL, Wang CY.   +6 more
europepmc   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Bridging pleiotropic mechanisms in leprosy type-1 reactions and neurodegenerative diseases. [PDF]

Sci Rep
Fava VM, Perico J, Orlova M, Dallmann-Sauer M, Xu YZ, Thuc NV, Thai VH, Belone AF, Latini ACP, Schurr E.   +9 more
europepmc   +1 more source

Tips and Pitfalls of Surgical Techniques for Scoliotic Deformities in Neurofibromatosis Type 1. [PDF]

J Clin Med
Kaspiris A, Lianou I, Marouglianis V, Afrati RS, Sakellariou E, Morakis A, Karampinas P, Vasilisadis ES, Pneumaticos SG.   +8 more
europepmc   +1 more source

Humanized Mouse Models for Type 1 Diabetes. [PDF]

Curr Protoc
Serreze DV, Tousey-Pfarrer M, Racine JJ.
europepmc   +1 more source

Delving into the genome of resurged Shigella dysenteriae Type 1. [PDF]

One Health Outlook
Pragasam AK, Chowdhury G, Das M, Khati R, Mukhopadhyay AK, Das S, Dutta S, Dolma KG, Ramamurthy T.   +8 more
europepmc   +1 more source

Glycemic Patterns and Breastfeeding With Type 1 or Type 2 Diabetes. [PDF]

Diabetes Spectr
Greenberg VR.
europepmc   +1 more source

A Novel SCNN1B Mutation in a Neonate With Systemic Pseudohypoaldosteronism Type 1: Case Report. [PDF]

Clin Case Rep
Bahadoran E, Saffari F, Moghbelinejad S.
europepmc   +1 more source